National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure
Population
Adult patients with etiologies other than acute coronary syndromes and heart failure, including chronic…
Design
Guideline
Authors
Discussion
Loading...
Member takes
Overview
Adopt dynamic troponin criteria for AMI diagnosis in ESRD; extends evidence-based biomarker guidance to chronic kidney disease.
Structured PICO
P
Population
Adult patients with etiologies other than acute coronary syndromes and heart failure, including chronic renal failure/end-stage renal disease, pulmonary embolism, critical care, noncardiac surgery, percutaneous coronary intervention, and cardiac surgery.
I
Intervention
Measurement of cardiac biomarkers (cardiac troponin, B-type natriuretic peptide, and N-terminal proB-type natriuretic peptide)
These guidelines establish evidence-based recommendations for the clinical use and interpretation of cardiac troponin and natriuretic peptides in conditions outside of acute coronary syndromes and heart failure, such as chronic renal failure.
Cite This Study
Wu et al. (2007) studied this question.